Literature DB >> 15916807

Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjögren's syndrome.

Lars Ottosson1, Janosch Hennig, Alexander Espinosa, Susanna Brauner, Marie Wahren-Herlenius, Maria Sunnerhagen.   

Abstract

Ro52, one of the major autoantigens in the rheumatic disease Sjögren's syndrome (SS), belongs to the tripartite motif (TRIM) or RING-B-box-coiled-coil (RBCC) protein family, thus comprising an N-terminal RING, followed by a B-box and a coiled-coil region. Several different proteomic functions have been suggested for Ro52, including DNA binding, protein interactions and Zn(2+)-binding. To analyze the presence and/or absence of these functions and, in particular, map those to different subregions, the modular composition of the Ro52 protein was experimentally characterized. Two structured parts of Ro52 were identified, corresponding to the RING-B-box and the coiled-coil regions, respectively. Secondary structure analysis by circular dichroism (CD) spectroscopy indicated that the two subregions are independently structured. The entire RING-B-box region displayed Zn(2+)-dependent stabilization against proteolysis in the presence of Zn2+, indicating functional Zn(2+)-binding sites in both the RING and the B-box. However, no stabilization with DNA was detected, irrespective of Zn(2+), thus suggesting that the RING-B-box region does not bind DNA. Oligomerization of the coiled-coil was investigated by analytical ultracentrifugation and in a mammalian two-hybrid system. Both methods show weak homodimer affinity, in parity with other coiled-coil domains involved in regulatory interactions. The C-terminal B30.2 region was rapidly degraded both during cellular expression and refolding, indicating a less stable structure. Immunologic analysis of the stable protein regions with sera from patients with Sjögren's syndrome shows that immunodominant epitopes to a large extent are localized in the structurally stable parts of Ro52. The results form a basis for further Ro52 functional studies on the proteome level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15916807     DOI: 10.1016/j.molimm.2005.04.013

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  16 in total

Review 1.  Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal / foetal dyad at risk.

Authors:  J P Buyon; R M Clancy; D M Friedman
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

2.  Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies.

Authors:  Linn Strandberg; Aurelie Ambrosi; Alexander Espinosa; Lars Ottosson; Maija-Leena Eloranta; Wei Zhou; Ase Elfving; Edward Greenfield; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

3.  Determinants of the higher order association of the restriction factor TRIM5alpha and other tripartite motif (TRIM) proteins.

Authors:  Xing Li; Darwin F Yeung; Ann M Fiegen; Joseph Sodroski
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

4.  Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.

Authors:  Xing Li; Yuan Li; Matthew Stremlau; Wen Yuan; Byeongwoon Song; Michel Perron; Joseph Sodroski
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjögren's syndrome.

Authors:  L A Aqrawi; M Kvarnström; K A Brokstad; R Jonsson; K Skarstein; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 6.  The spectrum of autoinflammatory diseases: recent bench to bedside observations.

Authors:  John G Ryan; Raphaela Goldbach-Mansky
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

7.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.

Authors:  Alexander Espinosa; Valerie Dardalhon; Susanna Brauner; Aurelie Ambrosi; Rowan Higgs; Fransisco J Quintana; Maria Sjöstrand; Maija-Leena Eloranta; Joan Ní Gabhann; Ola Winqvist; Birgitta Sundelin; Caroline A Jefferies; Björn Rozell; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

8.  Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Authors:  Charles R Langelier; Virginie Sandrin; Debra M Eckert; Devin E Christensen; Viswanathan Chandrasekaran; Steven L Alam; Christopher Aiken; John C Olsen; Alak Kanti Kar; Joseph G Sodroski; Wesley I Sundquist
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

9.  Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome.

Authors:  Peter D Burbelo; Hannah P Leahy; Alexandra T Issa; Sandra Groot; James N Baraniuk; Nikolay P Nikolov; Gabor G Illei; Michael J Iadarola
Journal:  Autoimmunity       Date:  2009-09       Impact factor: 2.815

10.  Rapid serological detection of autoantibodies associated with Sjögren's syndrome.

Authors:  Peter D Burbelo; Kathryn H Ching; Alexandra T Issa; Caroline M Loftus; Yi Li; Minoru Satoh; Westley H Reeves; Michael J Iadarola
Journal:  J Transl Med       Date:  2009-09-24       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.